Lets Talk Research 2015 - Professor Nicki Latham, Chief Operating Officer, He...NHSNWRD
Creating a flexible workforce that embraces research and innovation.
Professor Nicki Latham planned to discuss how Health Education England’s responsibility to create a flexible workforce that embraces research and innovation will help to address the challenges facing the health and social care system in the coming years. Nicki has a background in research and academia and is passionate about evidence based practice and decision making. The presentation will cover Nicki’s personal research journey; showcase HEE’s Research and Innovation Strategy and associated Clinical Academic Careers Framework; and explain how evidence-based practice can also help to facilitate changes in the workforce and education.
Andrea Whitehead & Lynne Walker - Maternity and Neonatal Learning System: smo...Innovation Agency
Presentation by Andrea Whitehead, Service Development Midwife, Lancashire Teaching Hospitals and Lynne Walker, Public Health Midwife, Lancashire Teaching Hospitals at Maternity and Neonatal Learning System: smoking in pregnancy event on Wednesday 11 September at Haydock Park Racecourse.
Mandy Townsend - Maternity and Neonatal Learning System: smoking in pregnancyInnovation Agency
Presentation by Mandy Townsend, Associate Director - Patient Safety Collaborative at Maternity and Neonatal Learning System: smoking in pregnancy event on Wednesday, 11 September at Haydock Park Racecourse.
NICE Guidance Prevention of STIs and Under 18 Conceptionsbpilmer
A quick reference guide presenting recommendations on 'one to one interentions to reduce the transmission of sexually transmitted infections (STIs) including HIV, and to reduce the rate of under 18 conceptions, especially among vulnerable and at risk groups.'
An annual two-day transformational platform for innovative ideas, corporate advocacy and trends that shape and drive change in the world of health and social development. The conference offers incredible breath of content, with world-class speakers and conversational leads from diverse fields, with one objective in mind - expanding the solution space.
Lets Talk Research 2015 - Professor Nicki Latham, Chief Operating Officer, He...NHSNWRD
Creating a flexible workforce that embraces research and innovation.
Professor Nicki Latham planned to discuss how Health Education England’s responsibility to create a flexible workforce that embraces research and innovation will help to address the challenges facing the health and social care system in the coming years. Nicki has a background in research and academia and is passionate about evidence based practice and decision making. The presentation will cover Nicki’s personal research journey; showcase HEE’s Research and Innovation Strategy and associated Clinical Academic Careers Framework; and explain how evidence-based practice can also help to facilitate changes in the workforce and education.
Andrea Whitehead & Lynne Walker - Maternity and Neonatal Learning System: smo...Innovation Agency
Presentation by Andrea Whitehead, Service Development Midwife, Lancashire Teaching Hospitals and Lynne Walker, Public Health Midwife, Lancashire Teaching Hospitals at Maternity and Neonatal Learning System: smoking in pregnancy event on Wednesday 11 September at Haydock Park Racecourse.
Mandy Townsend - Maternity and Neonatal Learning System: smoking in pregnancyInnovation Agency
Presentation by Mandy Townsend, Associate Director - Patient Safety Collaborative at Maternity and Neonatal Learning System: smoking in pregnancy event on Wednesday, 11 September at Haydock Park Racecourse.
NICE Guidance Prevention of STIs and Under 18 Conceptionsbpilmer
A quick reference guide presenting recommendations on 'one to one interentions to reduce the transmission of sexually transmitted infections (STIs) including HIV, and to reduce the rate of under 18 conceptions, especially among vulnerable and at risk groups.'
An annual two-day transformational platform for innovative ideas, corporate advocacy and trends that shape and drive change in the world of health and social development. The conference offers incredible breath of content, with world-class speakers and conversational leads from diverse fields, with one objective in mind - expanding the solution space.
In most Anglo-American countries, states, or provinces, some form of specific provision allowing young people to remain in care up to age of 21 (referred to here as ‘Extended Care’) has recently been, or is in the process of being, introduced. While defined and framed differently across jurisdictions, these initiatives allow some young people to transition from care at a time and in a way that better suits them, and is closer to the experience of other young people and young adults leaving home. This paper reports on a small study on identifying the international evidence base on extending care from 18 to 21. In doing so, and in order to help guide future developments in New Zealand, the study’s objectives were to identify: whether extending care ‘works’, for whom, and why; and any evidence in relation to design considerations on how to best implement such provision.
Health literacy in the WHO European Region, Dr Bente Mikkelsen, Director, Noncommunicable Diseases and Promoting Health through the Life-course / Kristina Mauer-Stender, Acting Director, Information, Evidence, Research and innovation (WHO Regional Office for Europe)
Tuire Santamäki-Vuori, Finnish Institute for Health and WelfareTHL
JPI More Years Better Lives workshop: Integrating policies, programmes and services in an ageing society (30 October 2019)
https://thl.fi/en/web/thlfi-en/whats-new/events/thl-s-eu-2019-side-events/demographic-change-equality-and-wellbeing
Presented by Claudia Stein, Director, Division of Information, Evidence, Research and Innovation, WHO/Europe, at the 64th session of the WHO Regional Committee for Europe.
aids conference 2014, hiv and aids, hiv interventions, hope program, kenya, nope kenya, people living with hiv, uptake of hiv testing and adherence to hiv treatment
"Quality Standards to Quality Assured Indicators: The End-to-End Process", presentation delivered by John Varlow (Director of Information Services - HSCIC) and Nick Baillie (Associate Director, Indicators, Health and Social Care Quality Team, NICE), at the Healthcare Efficiency Through Technology Expo 2013.
161207 iHV leadership conf - Sharin BaldwinJulie Cooper
Presentation by Sharin Baldwin, FiHV, NIHR Clinical Doctoral Fellow King's College London/ Health Visiting Clinical Academic Lead, London North West Healthcare Trust, t iHV leadership conference on 7 December 2016.
Leadership in Health Visiting
In most Anglo-American countries, states, or provinces, some form of specific provision allowing young people to remain in care up to age of 21 (referred to here as ‘Extended Care’) has recently been, or is in the process of being, introduced. While defined and framed differently across jurisdictions, these initiatives allow some young people to transition from care at a time and in a way that better suits them, and is closer to the experience of other young people and young adults leaving home. This paper reports on a small study on identifying the international evidence base on extending care from 18 to 21. In doing so, and in order to help guide future developments in New Zealand, the study’s objectives were to identify: whether extending care ‘works’, for whom, and why; and any evidence in relation to design considerations on how to best implement such provision.
Health literacy in the WHO European Region, Dr Bente Mikkelsen, Director, Noncommunicable Diseases and Promoting Health through the Life-course / Kristina Mauer-Stender, Acting Director, Information, Evidence, Research and innovation (WHO Regional Office for Europe)
Tuire Santamäki-Vuori, Finnish Institute for Health and WelfareTHL
JPI More Years Better Lives workshop: Integrating policies, programmes and services in an ageing society (30 October 2019)
https://thl.fi/en/web/thlfi-en/whats-new/events/thl-s-eu-2019-side-events/demographic-change-equality-and-wellbeing
Presented by Claudia Stein, Director, Division of Information, Evidence, Research and Innovation, WHO/Europe, at the 64th session of the WHO Regional Committee for Europe.
aids conference 2014, hiv and aids, hiv interventions, hope program, kenya, nope kenya, people living with hiv, uptake of hiv testing and adherence to hiv treatment
"Quality Standards to Quality Assured Indicators: The End-to-End Process", presentation delivered by John Varlow (Director of Information Services - HSCIC) and Nick Baillie (Associate Director, Indicators, Health and Social Care Quality Team, NICE), at the Healthcare Efficiency Through Technology Expo 2013.
161207 iHV leadership conf - Sharin BaldwinJulie Cooper
Presentation by Sharin Baldwin, FiHV, NIHR Clinical Doctoral Fellow King's College London/ Health Visiting Clinical Academic Lead, London North West Healthcare Trust, t iHV leadership conference on 7 December 2016.
Leadership in Health Visiting
Presentation by Dr Zsuzsanna Jakab,WHO Regional Director for Europe, at the Third High-level Meeting of the Small Countries Initiative, in Monaco, on 11–12 October 2016
Presented at the 66th session of the WHO Regional Committee for Europe by Dr Claudia Stein, Director,
Information, Evidence, Research and Innovation, WHO/Europe
Presentation – The Issue-based Coalition on Health and Well-being
12 May 2017, Geneva, Switzerland
By Dr Zsuzsanna Jakab, WHO Regional Director for Europe
presented by Zsuzsanna Jakab, WHO Regional Director for Europe on 18 November 2014 at Ministerial Meeting in Skopje, The former Yugoslav Republic of Macedonia
Resolutions and decisions of regional interest adopted by the Seventy-second World Health Assembly and the Executive Board at its 144th and 145th sessions
By Dr Zsuzsanna Jakab, WHO Regional Director for Europe at
Scientific conference: crossroad of policy, research, education and practice in primary health care
23 October 2018, Almaty, Kazakhstan
Transforming the workforce: funding, education and skillsLisa Bayliss-Pratt
In this presentation, given at a national conference on February 16, 2017, "Safer Maternity Care: Next Steps Towards the National Maternity Ambition" I cover key issues on achieving the goals of Better Birth and the Maternity Transformation Programme, including HEE's work on ensuring that training supports a culture of continuous learning and improvement in safe services.
Reported measles cases for the period November 2020—October 2021 (data as of 02 December 2021).A monthly summary of the epidemiological data on selected vaccine-preventable diseases in the WHO European Region
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
1. Nurses and Midwives:
a vital resource for health
Technical briefing,
Division of Health Systems and Public Health
Wednesday, 17 September 2014
2. Purpose of the briefing
To promote debate among Member States and
relevant stakeholders on how to strengthen
nursing and midwifery in order to maximize
their potential and enable their full
contributions for supporting
Health 2020 implementation
3. Documents for discussion
• Strengthening Nursing and Midwifery:
European strategic directions towards
Health 2020 goals
• Compendium of good practices in
nursing and midwifery
4. Expected outcomes
• To kick-start the consultation process on the framework “Strengthening
nursing and midwifery: European strategic directions towards Health
2020”
• To better understand the roles and contributions of nurses and
midwives to the health and well-being of the population, with a focus on
Health 2020 goals
• To engage political commitment to realize the potential of nursing and
midwifery to influence future progress in supporting Health 2020
implementation
5. From Munich - to Health 2020
and beyond…
“Nurses and midwives have key and
increasingly important roles to play in society’s
efforts to tackle the public health challenges of
our time and in ensuring the continuity of care
and addressing people’s rights and changing
needs”
Source: Health 2020: a European policy framework and strategy for the 21 century.
p.115
6. Key conclusions of the regional meeting
• Develop a shared strategic vision, aligned
with Health 2020
• Collect evidence, facilitate information
exchange and promote good practices
• Ensure political commitment and technical
collaboration
• Validate the strategic action and a way
forward
7. Working with partners and networks
to develop common strategic vision
WHO Regional Meeting of CNOs, Vilnius, October 2013 Regional network of CNOs, EFNNMA and WHO CCs
8. Strengthening Nursing and Midwifery:
European Strategic Direction towards Health 2020 goals
Common Health 2020 vision:
To improve health and well-being of populations and
to reduce health inequities
Priority areas
of action
Enabling
mechanisms
Scaling up and
transforming
education
Workforce planning
and optimizing
skill mix
Ensuring
attractive
work environment
Promoting evidence
based practice and
innovation
Regulation Research Partnerships Management
9. Collecting evidence to support policy framework
Common Health 2020 vision:
To improve health and well-being of populations and to reduce health inequities
Innovative, competent and motivated nursing and midwifery
workforce providing sustainable, safe and evidence based:
• patient centred care,
• health promotion
• disease prevention
Priority areas
of action
Enabling
mechanisms
Strengthening Nursing and Midwifery - European strategic directions towards Health 2020 goals
Scaling up and
transforming
education
Workforce planning
and optimizing
skill mix
Ensuring
attractive
work environment
Promoting evidence
based practice and
innovation
Regulation Research Partnerships Management
European
compendium on
good nursing and
midwifery practices
10. Compendium of good practices
55 case studies from 18 countries in Europe
Good practices in nursing and midwifery exist supporting Health 2020 implementation
Nurses and midwives – key actors in enhancing health
Empowering communities, promoting health through life course
Ensuring equal access and better continuum of care
Providing safe, efficient and quality care
11. The Roadmap towards 2015
Technical
briefing,
RC64
WHO CNOs
meeting for CIS
St. Petersburg
Regional
Committee:
sixty-fifth
session
Joint WHO & EU
CNOs meeting,
Lithuania
Joint WHO & EU
CNOs meeting,
Riga
EU CNOs
meeting, Cyprus
WHO Expert
group meeting,
WHO/Europe
Joint WHO & EU
CNOs meeting
Warsaw
Oct
2011
May
2012
Oct
2012
Oct
2013
Sep
2015
Sep
2014
Apr
2015
Editor's Notes
It might be useful to introduce the ESD here and talk about how it relates to Health 2020 and then the compendiums contribution, maybe?